DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.

[1]  D. Paulson,et al.  Isolation of a human prostate carcinoma cell line (DU 145) , 1978, International journal of cancer.

[2]  M. Bennett,et al.  EPIDERMAL-GROWTH-FACTOR RECEPTORS IN HUMAN BLADDER CANCER: COMPARISON OF INVASIVE AND SUPERFICIAL TUMOURS , 1985, The Lancet.

[3]  Hermona Soreq,et al.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin , 1985, Nature.

[4]  J. Farndon,et al.  EPIDERMAL-GROWTH-FACTOR RECEPTOR STATUS AS PREDICTOR OF EARLY RECURRENCE OF AND DEATH FROM BREAST CANCER , 1987, The Lancet.

[5]  L. Orci,et al.  The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes , 1990, The Journal of cell biology.

[6]  S. Aaronson,et al.  Growth factors and cancer. , 1991, Science.

[7]  L. Lund,et al.  Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain. , 1992, The Journal of biological chemistry.

[8]  Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. , 1993, Cancer research.

[9]  U. Rodeck,et al.  Autocrine/paracrine regulation of keratinocyte urokinase plasminogen activator through the TGF‐α/EGF receptor , 1993, Journal of cellular physiology.

[10]  A. Wells,et al.  Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement , 1994, The Journal of cell biology.

[11]  B. Zetter,et al.  Regulation of chemotaxis by the platelet-derived growth factor receptor-β , 1994, Nature.

[12]  S. Waxman,et al.  Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells , 1994, The Journal of cell biology.

[13]  E. Krebs,et al.  Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. , 1994, The Journal of clinical investigation.

[14]  R C Smith,et al.  Effect of epidermal growth factor on prostate cancer cell line PC3 growth and invasion , 1994, The Prostate.

[15]  A. Wells,et al.  Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis , 1994, The Journal of cell biology.

[16]  S. Capaccioli,et al.  Reversion of the invasive phenotype of transformed human fibroblasts by anti-messenger oligonucleotide inhibition of urokinase receptor gene expression. , 1995, Cancer research.

[17]  S. Rabbani,et al.  Induction of urinary plasminogen activator by retinoic acid results in increased invasiveness of human prostate cancer cells PC‐3 , 1995, The Prostate.

[18]  A. Wells,et al.  A role for gelsolin in actuating epidermal growth factor receptor- mediated cell motility , 1996, The Journal of cell biology.

[19]  E. Skrzypczak‐Jankun,et al.  Inhibitors of urokinase reduce size of prostate cancer xenografts in severe combined immunodeficient mice. , 1997, Cancer research.

[20]  A. Wells,et al.  Molecular inhibition of phospholipase cgamma signaling abrogates DU-145 prostate tumor cell invasion. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[21]  M. Hudson,et al.  Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines. , 1997, Journal of the National Cancer Institute.

[22]  Hua Tang,et al.  The Urokinase-type Plasminogen Activator Receptor Mediates Tyrosine Phosphorylation of Focal Adhesion Proteins and Activation of Mitogen-activated Protein Kinase in Cultured Endothelial Cells* , 1998, The Journal of Biological Chemistry.

[23]  M. Symons,et al.  The Transcription Factor AP-1 Is Required for EGF-induced Activation of Rho-like GTPases, Cytoskeletal Rearrangements, Motility, and In Vitro Invasion of A431 Cells , 1998, The Journal of cell biology.

[24]  S. L. Gonias,et al.  Binding of Urokinase-type Plasminogen Activator to Its Receptor in MCF-7 Cells Activates Extracellular Signal-regulated Kinase 1 and 2 Which Is Required for Increased Cellular Motility* , 1998, The Journal of Biological Chemistry.

[25]  H. Miyake,et al.  Elevation of urokinase-type plasminogen activator and its receptor densities as new predictors of disease progression and prognosis in men with prostate cancer. , 1999, International journal of oncology.

[26]  A. Wells,et al.  A Role for Phospholipase C-γ-mediated Signaling in Tumor Cell Invasion , 1999 .

[27]  A. Wells,et al.  EGF receptor signaling in prostate morphogenesis and tumorigenesis. , 1999, Histology and histopathology.

[28]  N. Shinomiya,et al.  Urokinase type plasminogen activator and its receptor regulate the invasive potential of gastric cancer cell lines. , 2000, International journal of oncology.

[29]  A. Wells,et al.  Tumor invasion: role of growth factor-induced cell motility. , 2000, Advances in cancer research.

[30]  P. Andreasen,et al.  The plasminogen activation system in tumor growth, invasion, and metastasis , 2000, Cellular and Molecular Life Sciences CMLS.

[31]  J. Roh,et al.  Tissue urokinase-type plasminogen activator receptor levels in breast cancer. , 2000, International journal of molecular medicine.

[32]  J. Kreidberg,et al.  Urokinase Receptors Promote β1 Integrin Function through Interactions with Integrin α3β1 , 2001 .

[33]  E. Skrzypczak‐Jankun,et al.  Binding site of amiloride to urokinase plasminogen activator depends on species. , 2001, International journal of molecular medicine.

[34]  J. Aguirre-Ghiso,et al.  Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. , 2001, Molecular biology of the cell.

[35]  A. Wells,et al.  Dolichol-phosphate-mannose-3 (DPM3)/prostin-1 is a novel phospholipase C-γ regulated gene negatively associated with prostate tumor invasion , 2001, Oncogene.

[36]  D A Lauffenburger,et al.  Tumor invasion as dysregulated cell motility. , 2001, Seminars in cancer biology.

[37]  Simon C Watkins,et al.  Distribution of gelsolin and phosphoinositol 4,5-bisphosphate in lamellipodia during EGF-induced motility. , 2002, The international journal of biochemistry & cell biology.

[38]  Yiwei Li,et al.  Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein. , 2002, Cancer letters.

[39]  L. Ossowski,et al.  EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. , 2002, Cancer cell.

[40]  Alan Wells,et al.  Cutting to the chase: calpain proteases in cell motility. , 2002, Trends in cell biology.

[41]  P. Carmeliet,et al.  uPAR: a versatile signalling orchestrator , 2002, Nature Reviews Molecular Cell Biology.

[42]  K. Shirasuna,et al.  Inhibition of epidermal growth factor‐induced invasion by dexamethasone and AP‐1 decoy in human squamous cell carcinoma cell lines , 2002, Journal of cellular physiology.

[43]  S. Rabbani,et al.  Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo. , 2002, Cancer research.

[44]  R. Leake,et al.  The effect of EGFR-related tyrosine kinase activity inhibition on the growth and invasion mechanisms of prostate carcinoma cell lines. , 2003, The International journal of biological markers.

[45]  M. Jo,et al.  Soluble Urokinase-type Plasminogen Activator Receptor Inhibits Cancer Cell Growth and Invasion by Direct Urokinase-independent Effects on Cell Signaling* , 2003, Journal of Biological Chemistry.

[46]  M. Jo,et al.  Epidermal Growth Factor Receptor-dependent and -independent Cell-signaling Pathways Originating from the Urokinase Receptor* , 2003, The Journal of Biological Chemistry.

[47]  S. Dixon,et al.  Noncatalytic domain of uPA stimulates human extravillous trophoblast migration by using phospholipase C, phosphatidylinositol 3-kinase and mitogen-activated protein kinase. , 2003, Experimental cell research.

[48]  H. Kido,et al.  Amiloride and urinary trypsin inhibitor inhibit urothelial cancer invasion. , 2003, European urology.

[49]  A. Wells,et al.  In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals , 1995, Clinical & Experimental Metastasis.

[50]  Walter E. Laug,et al.  Urokinase induces receptor mediated brain tumor cell migration and invasion , 1998, Journal of Neuro-Oncology.

[51]  S. Nakano,et al.  Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells , 2004, Clinical & Experimental Metastasis.

[52]  Philip Chen,et al.  EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells , 1996, Clinical & Experimental Metastasis.

[53]  F. Blasi,et al.  The urokinase plasminogen activator system in cancer: Recent advances and implication for prognosis and therapy , 2003, Cancer and Metastasis Reviews.